These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17991403)

  • 1. Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002.
    Pires de Miranda M; Carmo Gomes M; Rebelo de Andrade H
    Euro Surveill; 2007 Jun; 12(6):E7-8. PubMed ID: 17991403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units.
    Diedrich S; Claus H; Schreier E
    BMC Infect Dis; 2002 Feb; 2():2. PubMed ID: 11943068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus antibody levels and lameness among individuals in three regions of Ghana.
    Opare JKL; Odoom JK; Akweongo P; Afari EA; Pappoe M
    Hum Vaccin Immunother; 2019; 15(9):2050-2059. PubMed ID: 31265356
    [No Abstract]   [Full Text] [Related]  

  • 4. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to poliomyelitis in The Netherlands.
    Conyn-Van Spaendonck MA; de Melker HE; Abbink F; Elzinga-Gholizadea N; Kimman TG; van Loon T
    Am J Epidemiol; 2001 Feb; 153(3):207-14. PubMed ID: 11157405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [German Health survey 1997/98: immune status against poliomyelitis].
    Diedrich S; Claus H; Thierfelder W; Bellach BM; Schreier E
    Dtsch Med Wochenschr; 2000 May; 125(19):584-8. PubMed ID: 11320716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment.
    Alleman MM; Wannemuehler KA; Weldon WC; Kabuayi JP; Ekofo F; Edidi S; Mulumba A; Mbule A; Ntumbannji RN; Coulibaly T; Abiola N; Mpingulu M; Sidibe K; Oberste MS
    J Infect Dis; 2014 Nov; 210 Suppl 1():S62-73. PubMed ID: 25316879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
    Opare JK; Akweongo P; Afari EA; Odoom JK
    Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results.
    Patti AM; Santi AL; Vulcano A; Casagni L; Lamberti A; De Stefano Caraffa D; Vellucci L; Fiore L; Fara GM
    Ann Ig; 2002; 14(4 Suppl 5):1-57. PubMed ID: 12389292
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    Pauly M; Black AP; Khampanisong P; Nouanthong P; Hübschen JM; Nanthavong N; Sayasinh K; Jutavijittum P; Samountry B; Xeuatvongsa A; Diedrich S; Muller CP
    PLoS One; 2018; 13(5):e0197370. PubMed ID: 29763458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
    Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
    BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National serosurvey of poliovirus immunity in Australia, 1996-99.
    Gidding HF; Backhouse JL; Gilbert GL; Burgess MA
    Aust N Z J Public Health; 2005 Feb; 29(1):48-52. PubMed ID: 15782872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australia's polio risk.
    Martin N; Paterson BJ; Durrheim DN
    Commun Dis Intell Q Rep; 2014 Jun; 38(2):E107-13. PubMed ID: 25222205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
    Giwa FJ; Olayinka AT; Ogunshola FT
    Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Poliovirus Antibodies in the United States Population, 2009-2010.
    Wallace GS; Curns AT; Weldon WC; Oberste MS
    BMC Public Health; 2016 Aug; 16():721. PubMed ID: 27492318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against poliomyelitis in Europe.
    Nokleby H; De Carvalho Gomes H; Johansen K; Kreidl P
    Euro Surveill; 2010 Apr; 15(17):. PubMed ID: 20460087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
    Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
    Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
    Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
    Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
    Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
    Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.